One ‐year follow‐up of a TRASER clinical trial for the treatment of nasal telangiectasias

ConclusionsThe TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1‐year follow‐up. Lasers Surg. Med. © 2017 Wiley Periodicals, Inc.

Source: Lasers in Surgery and Medicine - November 1, 2017 Category: Laser Surgery Authors: Elizabeth Geddes ‐Bruce, Selina S. Hamill, Christopher B. Zachary, Paul M. Friedman Tags: Clinical Reports Source Type: research